NewsStocksChoksi Laboratories Reappoints Vyangesh Choksi as Whole Time Director for Five-Year TermChoksi Laboratories Reappoints Vyangesh Choksi as Whole Time Director for Five-Year Term
Choksi Laboratories Limited has announced the reappointment of Vyangesh Choksi as Whole Time Director for a five-year term from September 1, 2025, to August 31, 2030, subject to shareholder approval. The decision was made during a board meeting on August 13, 2025. The company also approved financial results, set the date for the 32nd AGM, and made auditor appointments. Vyangesh Choksi is part of the promoter family, with other family members holding key positions in the company.
*this image is generated using AI for illustrative purposes only.
Choksi Laboratories Limited, a prominent player in the laboratory services sector, has announced the reappointment of Mr. Vyangesh Choksi as Whole Time Director for an extended five-year term. The decision, made during a board meeting on August 13, 2025, is subject to shareholder approval at the upcoming General Meeting.
Key Details of the Reappointment
- Term: Mr. Choksi's new term will run from September 1, 2025, to August 31, 2030.
- Approval Process: The reappointment was recommended by the Nomination and Remuneration Committee and approved by the Board of Directors.
- Shareholder Approval: The decision is pending ratification at the forthcoming General Meeting.
About Vyangesh Choksi
Mr. Vyangesh Choksi is a promoter member of Choksi Laboratories Limited with extensive experience in management and administration. His reappointment underscores the company's confidence in his leadership and vision.
Family Ties in Management
The reappointment highlights the strong family presence in Choksi Laboratories' top management:
- Sunil Choksi: Managing Director (Father of Vyangesh Choksi)
- Stela Choksi: Whole Time Director (Mother)
- Himika Choksi: Whole Time Director (Sister)
Other Board Decisions
In the same board meeting, Choksi Laboratories Limited made several other significant decisions:
- Financial Results: Approved the unaudited standalone financial results for the quarter ended June 30, 2025.
- Annual General Meeting: Set the date for the 32nd Annual General Meeting (AGM) for September 16, 2025, to be held via video conferencing.
- Auditor Appointments:
- Appointed M/s Surabhi Agrawal & Associates as Secretarial Auditor for a five-year term (FY 2025-2026 to FY 2029-2030).
- Reappointed M/s Tanmay V. Rajurkar & Co. as Internal Auditor for FY 2025-26.
Conclusion
The reappointment of Vyangesh Choksi as Whole Time Director for another five-year term reflects Choksi Laboratories' commitment to maintaining stable leadership. This continuity in management is expected to play a crucial role in the company's future strategies and operations within the laboratory services sector.
Historical Stock Returns for Choksi Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.19% | +7.87% | +12.99% | +64.95% | +237.68% | +2,063.27% |
17
